Durability of Response in Children Treated With Pegylated Interferon alfa‐2a ± Ribavirin for Chronic Hepatitis C

201518 citationsJournal Articlegreen Open Access

Authors

Kathleen B. Schwarz · Johns Hopkins University

Jean P. Molleston · Indiana University School of Medicine

Maureen M. Jonas · Boston Children's Museum

Jessica Wen · University of Pennsylvania

Karen F. Murray · Seattle Children's Hospital

Philip Rosenthal · University of California, San Francisco

Regino P. González‐Peralta

Abstract

Long-term durability of SVR is excellent following PegIFN alfa-2a treatment in children with chronic hepatitis C; SVR is higher in those with IL28B CC versus non-CC.

Topics & Keywords

Hepatitis C virus research Hepatitis B Virus Studies Liver Disease Diagnosis and Treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Pediatric Gastroenterology and Nutrition

Volume 62, Issue 1, pp. 93-96

DOI: 10.1097/mpg.0000000000000929

Field-Weighted Citation Impact: 1.72